Teva Pharmaceuticals USA, Inc., v. GlaxoSmithKline, LLC
Certiorari Denied
Petition for certiorari denied on May 15, 2023.
Issue
Whether a generic drug manufacturer's FDA-approved label that carves out all of the language the brand manufacturer has identified as covering its patented uses can be held liable on a theory that its label still intentionally encourages infringement of those carved-out uses.
Apr 29, 2022Application (21A677) to extend the time to file a petition for a writ of certiorari from May 12, 2022 to July 11, 2022, submitted to The Chief Justice.
May 3, 2022Application (21A677) granted by The Chief Justice extending the time to file until July 11, 2022.
Jul 11, 2022Petition for a writ of certiorari filed. (Response due August 12, 2022)Jul 25, 2022Motion to extend the time to file a response from August 12, 2022 to September 12, 2022, submitted to The Clerk.Jul 26, 2022Motion to extend the time to file a response is granted and the time is extended to and including September 12, 2022.
Aug 10, 2022Brief amici curiae of 42 Professors of Law, Economics, Business, and Medicine filed.Aug 12, 2022Brief amicus curiae of Alvotech filed.Aug 12, 2022Brief amicus curiae of Mylan Pharmaceuticals Inc. filed.Aug 12, 2022Brief amicus curiae of Association for Accessible Medicines filed.Aug 19, 2022Brief of respondents GlaxoSmithKline LLC, et al. in opposition filed.Sep 7, 2022DISTRIBUTED for Conference of 9/28/2022.
Sep 7, 2022Reply of petitioner Teva Pharmaceuticals USA, Inc. filed. (Distributed)Oct 3, 2022The Solicitor General is invited to file a brief in this case expressing the views of the United States.
Mar 29, 2023Brief amicus curiae of United States filed.Apr 11, 2023Supplemental brief of respondents GlaxoSmithKline LLC, et al. filed. (Distributed)Apr 12, 2023DISTRIBUTED for Conference of 4/28/2023.
May 8, 2023DISTRIBUTED for Conference of 5/11/2023.
May 15, 2023Petition DENIED. Justice Kavanaugh would grant the petition for a writ of certiorari.
Recommended Citation: Teva Pharmaceuticals USA, Inc., v. GlaxoSmithKline, LLC, SCOTUSblog, https://www.scotusblog.com/cases/teva-pharmaceuticals-usa-inc-v-glaxosmithkline-llc/